To: Board of Supervisors
From: Anna Roth, Health Services Director
Report Title: Laboratory Interface System Agreement #23-868 and Amendment #76-556-7 with Laboratory Corporation of America
☒Recommendation of the County Administrator ☐ Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Health Services Director, or designee, to execute on behalf of the County, the following: (1) a Laboratory Interface System (LIS) Agreement #23-868 with Laboratory Corporation of America, , a corporation, to establish a laboratory testing interface for the period December 1, 2024 through November 30, 2027, and (2) Amendment Agreement #76-556-7 with Laboratory Corporation of America, a corporation, to amend Contract #76-556-5 (as amended by Amendment Agreement #76-556-6), effective December 1, 2024, to incorporate the Laboratory Interface System Agreement with no change in the payment limit of $325,000 or term of May 1, 2023 through April 30, 2026.
FISCAL IMPACT:
Approval of this board action will not impact the budgeted expenditures of up to $325,000 over a 3-year period funded 100% by Hospital Enterprise Fund I.
BACKGROUND:
CCRMC and Contra Costa Health Centers have an obligation to provide laboratory testing services to patients. On occasion, the County contracts with outside laboratory testing services in order to provide testing that requires special equipment not available at County facilities. CCRMC’s Pathology laboratory sends out test(s) for consultation, such as Human papillomavirus (HPV) for pap co-test, Immunohistochemistry (IHC) for diagnostic treatment of disease, her2fish for breast treatment and flow cytometry for diagnosis of leukemia as well as clinical lab testing when needed. This Contractor has been providing outside clinical laboratory testing services for CCRMC since May 2017.
Contract #76-556-5 was entered into under and subject to the following legal authorities: California Government Code §§ 26227 and 31000. Health Services Personnel approved this Contract to ensure no conflicts with labor relations. Contractor is a member of the Vizient Group Purchasing Organization (GPO) and per Administrative Bulletin 600.3, GPO members are exempt from solicitation requirements.
On October 3, 2023, the Board of Supervisors approved Contract #76-556-5 with Laboratory Corporation of America in an amount not to exceed $325,000 to provide outside laboratory testing services, including HER2FISH test for breast cancer treatment, and flow cytometry test for leukemia treatment for the period from May 1, 2023 through April 30, 2026.
On September 24, 2024, the Board of Supervisors approved Amendment Agreement #76-556-6 with Laboratory Corporation of America, effective September 1, 2024, to provide additional outside laboratory testing services, with no change in the payment limit or term through April 30, 2026.
Approval of LIS Agreement #23-868 and Amendment Agreement #76-556-7 will allow County and Contractor to establish a customized computer interface to facilitate efficient communication for outside laboratory testing services.
CONSEQUENCE OF NEGATIVE ACTION:
If this Amendment is not approved, County will not be able to establish a customized computer interface to facilitate efficient communication for outside laboratory testing services.